Figure 27

![Figure 27: Pediatric epilepsy syndrome-specific responses to phytocannabinoids are reviewed. Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex show varying degrees of cannabidiol responsiveness.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="Pediatric epilepsy syndrome-specific responses to phytocannabinoids are reviewed. Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex show varying degrees of cannabidiol responsiveness." />
  <figcaption>Figure 27. Pediatric epilepsy syndrome-specific responses to phytocannabinoids are reviewed. Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex show varying degrees of cannabidiol responsiveness.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>